脓毒症相关急性肾损伤早期预测的研究进展
Research Progress in Early Prediction of Sep-tic Associated Acute Kidney Injury
DOI: 10.12677/ACM.2022.1281162, PDF,   
作者: 李文敬：青海大学研究生院，青海 西宁；侯 明*：青海大学附属医院急诊，青海 西宁
关键词: 脓毒症；急性肾损伤；早期预测；肾阻力指数；新型生物标志物；Sepsis； Acute Kidney Injury； Early Prediction； Renal Resistance Index； Novel Biomarkers
摘要: 脓毒症作为ICU常见疾病，病死率一直居高不下，特别是脓毒症引发的AKI，是造成患者病死率显著升高的重要原因，脓毒症引发的AKI的发生率在40%左右。那么，及时准确的预测脓毒症患者AKI的发生，避免进一步的肾脏损害，早期及时的治疗，对患者的预后及生活质量有很大的影响，这篇综述的目的是探讨RI (肾动脉阻力指数)及早期标志物在预测脓毒症患者发生急性肾损伤的早期诊断的研究进展。
Abstract: Sepsis, as a common disease in ICU, has a high fatality rate, especially sepsis induced AKI, which is an important reason for the significant increase in the fatality rate of patients. The incidence rate of SEPSIS induced AKI is about 40%. Then, in time accurately predicting the occurrence of AKI in pa-tients with sepsis, avoiding further renal damage, and providing early and timely treatment have a great impact on the prognosis and quality of life of patients. The purpose of this review is to inves-tigate the RI (renal artery resistance index) and early marker in predicting sepsis patients in the early diagnosis of acute kidney injury.
文章引用：李文敬, 侯明. 脓毒症相关急性肾损伤早期预测的研究进展[J]. 临床医学进展, 2022, 12(8): 8071-8076. https://doi.org/10.12677/ACM.2022.1281162

参考文献

[1] 戴甜, 曹书华, 杨晓龙. 连续性肾脏替代治疗与间歇性血液透析对脓毒症急性肾损伤的临床疗效比较[J]. 中华危重病急救医学, 2016, 28(3): 277-280.
[2] 张继翱, 李家瑞, 乔佑杰, 尚跃丰, 宋石林. 血必净注射液治疗脓毒症急性肾损伤的临床疗效及对炎症因子的影响[J]. 天津中医药, 2016, 33(1): 13-17.
[3] 王敏, 刘虹, 程威. 脓毒症急性肾损伤早期生物标志物的新进展[J]. 中国临床研究, 2016, 29(3): 424-426.
[4] Uchino, S., Kellum, J.A., Bellomo, R., Doig, G.S., Morimatsu, H., Morgera, S., et al. (2005) Acute Renal Failure in Critically Ill Patients: A Mul-tinational, Multicenter Study. JAMA, 294, 813-818. [Google Scholar] [CrossRef] [PubMed]
[5] Bagshaw, S.M., Uchino, S., Bellomo, R., et al. (2007) Septic Acute Kidney Injury in Critically Ill Patients: Clinical Characteristics and Outcomes. Clinical Journal of the American Society of Nephrology, 2, 431-439. [Google Scholar] [CrossRef] 
[6] Bouchard, J., Acharya, A., Cerda, J., et al. (2015) A Prospective In-ternational Multicenter Study of AKI in the Intensive Care Unit. Clinical Journal of the American Society of Nephrology, 10, 1324-1331. [Google Scholar] [CrossRef] 
[7] Hoste, E.A., Bagshaw, S.M., Bellomo, R., et al. (2015) Epidemiology of Acute Kidney Injury in Critically Ill Patients: The Multinational AKI-EPI Study. Intensive Care Medicine, 41, 1411-1423. [Google Scholar] [CrossRef] [PubMed]
[8] Adhikari, N.K., Fowler, R.A., Bhagwanjee, S., et al. (2010) Crit-ical Care and the Global Burden of Critical Illness in Adults. Lancet, 376, 1339-1346. [Google Scholar] [CrossRef] 
[9] Murugan, R., Karajala-Subramanyam, V., Lee, M., et al. (2010) Acute Kidney Injury in Non-Severe Pneumonia Is Associated with an Increased Immune Response and Lower Survival. Kidney Internatio, 77, 527-535. [Google Scholar] [CrossRef] [PubMed]
[10] Vincent, J.L., Sakr, Y., Sprung, C.L., et al. (2006) Sepsis in European Intensive Care Units: Results of the SOAP Study. Critical Care Medicine, 34, 344-353. [Google Scholar] [CrossRef] 
[11] Xu, X., Nie, S., Liu, Z., et al. (2015) Epidemiology and Clinical Correlates of AKI in Chinese Hospitalized Adults. Clinical Journal of the American Society of Nephrology, 10, 1510-1518. [Google Scholar] [CrossRef] 
[12] Jin, K., Murugan, R., Sileanu, F.E., et al. (2017) In-tensive Monitoring of Urine Output Is Associated with Increased Detection of Acute Kidney Injury and Improved Out-comes. Chest, 152, 972-979. [Google Scholar] [CrossRef] [PubMed]
[13] Kellum, J.A., Sileanu, F.E., Murugan, R., Lucko, N., Shaw, A.D. and Clermont, G. (2015) Classifying AKI by Urine Output versus Serum Creatinine Level. Journal of the American So-ciety of Nephrology, 26, 2231-2238. [Google Scholar] [CrossRef] 
[14] Quan, S., Pannu, N., Wilson, T., et al. (2016) Prognostic Implica-tions of Adding Urine Output to Serum Creatinine Measurements for Staging of Acute Kidney Injury after Major Sur-gery: A Cohort Study. Nephrology Dialysis Transplantation, 31, 2049-2056. [Google Scholar] [CrossRef] [PubMed]
[15] Nejat, M., Pickering, J.W., Walker, R.J. and Endre, Z.H. (2010) Rapid Detection of Acute Kidney Injury by Plasma Cystatin C in the Intensive Care Unit. Nephrology Dialysis Transplantation, 25, 3283-3289. [Google Scholar] [CrossRef] [PubMed]
[16] Herget-Rosenthal, S., Marggraf, G., Hüsing, J., Göring, F., Pietruck, F., Janssen, O., et al. (2004) Early Detection of Acute Renal Failure by Serum Cystatin C. Kidney International, 66, 1115-1122. [Google Scholar] [CrossRef] [PubMed]
[17] Bagshaw, S.M. and Gibney, R.T. (2008) Conventional Markers of Kidney Function. Critical Care Medicine, 36, S152-S158. [Google Scholar] [CrossRef] 
[18] Aydoğdu, M., Gürsel, G., Sancak, B., Yeni, S., Sarı, G., Taşyürek, S., et al. (2013) The Use of Plasma and Urine nEutrophil Gelatinase Associated Lipocalin (NGAL) and Cysta-tin C in Early Diagnosis of Septic Acute Kidney Injury in Critically Ill Patients. Disease Markers, 34, Article ID: 740351. [Google Scholar] [CrossRef] [PubMed]
[19] Doi, K., Yuen, P.S., Eisner, C., Hu, X., Leelahavanichkul, A., Schnermann, J., et al. (2009) Reduced Production of Creatinine Limits Its Use as Marker of Kidney Injury in Sepsis. Journal of the American Society of Nephrology, 20, 1217-1221. [Google Scholar] [CrossRef] 
[20] Poston, J.T. and Koyner, J.L. (2019) Sepsis Associated Acute Kidney Injury. BMJ, 364, Article No. k4891. [Google Scholar] [CrossRef] [PubMed]
[21] Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney In-jury Work Group (2012) KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements, 2, 1-138.
[22] Leedahl, D.D., Frazee, E.N., Schramm, G.E., et al. (2014) Derivation of Urine Output Thresholds That Identify a Very High Risk of AKI in Patients with Septic Shock. Clinical Journal of the American Society of Nephrology, 9, 1168-1174. [Google Scholar] [CrossRef] 
[23] Pravisani, R., Baccarani, U., Langiano, N., et al. (2020) Predictive Value of Intraoperative Doppler Flowmetry for Delayed Graft Function in Kidney Transplantation: A Pilot Study. Trans-plantation Proceedings, 52, 1556-1558. [Google Scholar] [CrossRef] [PubMed]
[24] Wang, Z., Xiao, J., Zhang, Z., Qiu, X. and Chen, Y. (2018) Chronic Kidney Disease Can Increase the Risk of Preoperative Deep Vein Thrombosis in Middle-Aged and Elderly Pa-tients with Hipfractures. Clinical Interventions in Aging, 13, 1669-1674. [Google Scholar] [CrossRef] 
[25] Platt, J. (1992) Doppler Evaluation of Native Kidney Dysfunction: Ob-structive and Nonobstructive Disease. American Journal of Roentgenolog, 158, 1035-1042. [Google Scholar] [CrossRef] [PubMed]
[26] Wang, H., Feng, Q., Li, C., Zhang, H. and Peng, Y. (2022) Ultra-sonographic Study of Hemodynamics and Contrast-Enhanced Ultrasound in the Rhesus Monkey Kidney. Experimental Animals, 71, 116-122. [Google Scholar] [CrossRef] [PubMed]
[27] Kolonko, A., Chudek, J. and Więcek, A. (2018) Relationship be-tween Individual Components of the Extended-Criteria Donor Definition and the First Post-Transplant Kidney Graft Re-sistance Index, Measuredby Doppler Sonography. Transplantation Proceedings, 50, 1680-1685. [Google Scholar] [CrossRef] [PubMed]
[28] Bagshaw, S.M. and Bellomo, R. (2010) Cystatin C in Acute Kidney Injury. Current Opinion in Critical Care, 16, 533-539. [Google Scholar] [CrossRef] 
[29] Segarra, A., de la Torre, J., Ramos, N., Quiroz, A., Garjau, M., Torres, I., et al. (2011) Assessing Glomerular Filtration Rate in Hospitalized Patients: A Comparison between CKD-EPI and Four Cystatin C-Based Equations. Clinical Journal of the American Society of Nephrology, 6, 2411-2420. [Google Scholar] [CrossRef] 
[30] Dharnidharka, V.R., Kwon, C. and Stevens, G. (2002) Serum Cysta-tin C Is Superior to Serum Creatinine as a Marker of Kidney Function: A Meta-Analysis. American Journal of Kidney Diseases, 40, 221-226. [Google Scholar] [CrossRef] [PubMed]
[31] Cruz, D.N., de Geus, H.R. and Bagshaw, S.M. (2011) Biomarker Strategies to Predict Need for Renal Replacement Therapy in Acute Kidney Injury. Seminars in Dialysis, 24, 124-131. [Google Scholar] [CrossRef] 
[32] Ahlström, A., Tallgren, M., Peltonen, S, and Pettilä, V. (2004) Evolution and Predictive Power of Serum Cystatin C in Acute Renal Failure. Clinical Nephrology, 62, 344-350. [Google Scholar] [CrossRef] 
[33] Di Nardo, M., Ficarella, A., Ricci, Z., Luciano, R., Stoppa, F., Picardo, S., et al. (2013) Impact of Severe Sepsis on Serum and Urinary Biomarkers of Acute Kidney Injury in Critically Ill Children: An Observational Study. Blood Purification, 35, 172-176. [Google Scholar] [CrossRef] [PubMed]
[34] Leem, A.Y., Park, M.S., Park, B.H., Jung, W.J., Chung, K.S., Kim, S.Y., Kim, E.Y., Jung, J.Y., Kang, Y.A., Kim, Y.S., Kim, S.K., Chang, J. and Song, J.H. (2017) Value of Serum Cystatin C Measurement in the Diagnosis of Sepsis-Induced Kidney Injury and Prediction of Renal Function Recovery. Yonsei Medical Journal, 58, 604-612.
[35] Haase, M., Bellomo, R., Devarajan, P., et al. (2009) Accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Diagnosis and Progno-sis in Acute Kidney Injury: A Systematic Review and Meta-Analysis. American Journal of Kidney Diseases, 54, 1012-1024. [Google Scholar] [CrossRef] [PubMed]
[36] Haase, M., Devarajan, P., Haase-Fielitz, A., et al. (2011) The Outcome of Neutrophil Gelatinase-Associated Lipocalin-Positive Subclinical Acute Kidney Injury: A Multi-center Pooled Analysis of Prospective Studies. Journal of the American College of Cardiology, 57, 1752-1761. [Google Scholar] [CrossRef] [PubMed]
[37] Bagshaw, S.M., Bennett, M., Haase, M., et al. (2010) Plasma and Urine Neutrophil Gelatinase-Associated Lipocalin in Septic versus Non-Septic Acute Kidney Injury in Critical Illness. Intensive Care Medicine, 36, 452-461. [Google Scholar] [CrossRef] [PubMed]
[38] Srisawat, N., Murugan, R., Lee, M., et al. (2011) Plasma Neu-trophil Gelatinase-Associated Lipocalin Predicts Recovery from Acute Kidney Injury Following Community-Acquired Pneumonia. Kidney International, 80, 545-552. [Google Scholar] [CrossRef] [PubMed]
[39] Lubell, T.R., Barasch, J.M., Xu, K., et al. (2017) Urinary Neutrophil Gelatinase-Associated Lipocalin for the Diagnosis of Urinary Tract Infections. Pediatrics, 140, Article ID: e20171090. [Google Scholar] [CrossRef] [PubMed]
[40] Shao, X., Tian, L., Xu, W., et al. (2014) Diagnostic Value of Urinary Kidney Injury Molecule 1 for Acute Kidney Injury: A Meta-Analysis. PLOS ONE, 9, Article No. e84131. [Google Scholar] [CrossRef] [PubMed]
[41] Tu, Y., Wang, H., Sun, R., et al. (2014) Urinary Netrin-1 and KIM-1 as Early Biomarkers for Septic Acute Kidney Injury. Renal Failure, 36, 1559-1563. [Google Scholar] [CrossRef] 
[42] Noiri, E., Doi, K., Negishi, K., Tanaka, T., Hamasaki, Y., Fujita, T., et al. (2009) Urinary Fatty Acid-Binding Protein 1: An Early Predictive Biomarker of Kidney Injury. American Journal of Physiology. Renal Physiology, 296, F669-F679. [Google Scholar] [CrossRef] [PubMed]
[43] Cruz, D.N., Perazella, M.A., Bellomo, R., de Cal, M., Polanco, N., Corradi, V., Lentini, P., Nalesso, F., Ueno, T., Ranieri, V.M. and Ronco, C. (2007) Effectiveness of Polymyxin B-Immobilized Fiber Column in Sepsis: A Systematic Review. Critical Care, 11, Article No. R47. [Google Scholar] [CrossRef] [PubMed]
[44] Nakamura, T., Sugaya, T. and Koide, H. (2008) Urinary Liver-Type Fatty Acid-Binding Protein in Septic Shock: Effect of Polymyxin B-Immobilized Fiber Hemoperfusion. Shock, 31, 454-459. [Google Scholar] [CrossRef] 

为你推荐